Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections
Aslaa Ahmed, Gavriella Siman-Tov, Forrest Keck, et al.
Antiviral Research (2019) Vol. 164, pp. 61-69
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Antiviral peptides as promising therapeutic drugs
Liana Costa Pereira Vilas Boas, Marcelo Lattarulo Campos, Rhayfa Lorrayne Araújo Berlanda, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 18, pp. 3525-3542
Open Access | Times Cited: 284
Human Antimicrobial Peptides as Therapeutics for Viral Infections
Aslaa Ahmed, Gavriella Siman-Tov, Grant Hall, et al.
Viruses (2019) Vol. 11, Iss. 8, pp. 704-704
Open Access | Times Cited: 198
Antiviral Peptides: Identification and Validation
Garima Agarwal, Reema Gabrani
International Journal of Peptide Research and Therapeutics (2020) Vol. 27, Iss. 1, pp. 149-168
Open Access | Times Cited: 123
Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
Bapi Pahar, Stefania Madonna, Arpita Das, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 517-517
Open Access | Times Cited: 90
Antiviral Activities of Human Host Defense Peptides
David C. Brice, Gill Diamond
Current Medicinal Chemistry (2019) Vol. 27, Iss. 9, pp. 1420-1443
Open Access | Times Cited: 86
Antiviral and Immunomodulatory Properties of Antimicrobial Peptides Produced by Human Keratinocytes
Céline Chessa, Charles Bodet, Clément Jousselin, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 77
Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D
Ming-Yieh Peng, Wen-Chih Liu, Jing-Quan Zheng, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5251-5251
Open Access | Times Cited: 62
Understanding the Roles of Host Defense Peptides in Immune Modulation: From Antimicrobial Action to Potential as Adjuvants
Ju Kim, Byeol-Hee Cho, Yong‐Suk Jang
Journal of Microbiology and Biotechnology (2023) Vol. 33, Iss. 3, pp. 288-298
Open Access | Times Cited: 32
A review of the antiviral activity of cationic antimicrobial peptides
Umme Laila Urmi, Ajay Kumar Vijay, Rajesh Kuppusamy, et al.
Peptides (2023) Vol. 166, pp. 171024-171024
Open Access | Times Cited: 28
Challenges and Opportunities for Celecoxib Repurposing
Urszula Bąk, Anna Krupa
Pharmaceutical Research (2023) Vol. 40, Iss. 10, pp. 2329-2345
Open Access | Times Cited: 27
Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems
Ming Yang, Shuai Liu, Chunye Zhang
Current Research in Biotechnology (2023) Vol. 5, pp. 100121-100121
Open Access | Times Cited: 26
Antimicrobial peptides as antimicrobials for wound care management: A comprehensive review
Kunal Agam Kanaujia, Nidhi Mishra, P.S. Rajinikanth, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 95, pp. 105570-105570
Closed Access | Times Cited: 10
Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37
Mardi A. Crane‐Godreau, Kathleen J. Clem, P. M. Payne, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 57
Cathelicidins Target HSP60 To Restrict CVB3 Transmission via Disrupting the Exosome and Reducing Cardiomyocyte Apoptosis
Yang Yang, Chunjing Huang, Hui Li, et al.
Journal of Virology (2023) Vol. 97, Iss. 3
Open Access | Times Cited: 17
Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2
Santosh K. Ghosh, Aaron Weinberg
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 37
Natural antimicrobial peptides as a source of new antiviral agents
Hovakim Zakaryan, Garri Chilingaryan, Erik Arabyan, et al.
Journal of General Virology (2021) Vol. 102, Iss. 9
Open Access | Times Cited: 34
Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity
Patrick M. Tate, Vincent Mastrodomenico, Christina Cunha, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 8, pp. 1508-1522
Open Access | Times Cited: 15
Potential “biopeptidal” therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs
Tolulope Joshua Ashaolu, Asad Nawaz, Noman Walayat, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 9, pp. 3457-3470
Open Access | Times Cited: 32
Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
Jasleen Saini, Pritpal Kaur, Naveen Malik, et al.
Microbiological Research (2022) Vol. 265, pp. 127206-127206
Open Access | Times Cited: 19
Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions
Iman Owliaee, Mehran Khaledian, Ali Shojaeian, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
The Virus Entry Pathway Determines Sensitivity to the Antiviral Peptide TAT-I24
Eva Kicker, Antonio Kouros, Kurt Zatloukal, et al.
Viruses (2025) Vol. 17, Iss. 4, pp. 458-458
Open Access
The potentials of short fragments of human anti-microbial peptide LL-37 as a novel therapeutic modality for diseases
Keqiang Chen, Wanghua Gong, Jiaqiang Huang, et al.
Frontiers in Bioscience-Landmark (2021) Vol. 26, Iss. 11
Open Access | Times Cited: 25
Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic
Maria Rosa Loffredo, Lucia Nencioni, Maria Luisa Mangoni, et al.
Journal of Peptide Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 10
Antiviral activity of the host defense peptide piscidin 1: investigating a membrane-mediated mode of action
Tristan Bepler, Michael D. Barrera, Mary T. Rooney, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 3
Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy
Ping Ho, Jing-Quan Zheng, Chia‐Chao Wu, et al.
International Journal of Medical Sciences (2020) Vol. 18, Iss. 2, pp. 314-324
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top